Global Core Electronic Medicinal Product Information (ePI)
1.1.0 - trial-use International flag

Global Core Electronic Medicinal Product Information (ePI), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/emedicinal-product-info/ and changes regularly. See the Directory of published versions

: Composition - Type 2 Paracetamol

Page standards status: Informative

Raw xml | Download


<Composition xmlns="http://hl7.org/fhir">
  <id value="composition-epi-type2-example-paracetamol"/>
  <meta>
    <versionId value="1"/>
    <lastUpdated value="2023-01-25T10:00:00Z"/>
    <profile
             value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/composition-epi-type1"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="generated"/>
    <div xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en"><p>Package Leaflet: Information for the user - Paracetamol Tablets</p></div>
  </text>
  <contained>
    <Binary>
      <id value="binaryImage-t2"/>
      <meta>
        <profile
                 value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/binary-epi"/>
      </meta>
      <contentType value="image/png"/>
      <data
            value="iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mNkYAAAAAYAAjCB0C8AAAAASUVORK5CYII="/>
    </Binary>
  </contained>
  <identifier>
    <system value="http://example.org/identifier"/>
    <value value="composition-epi-type2-example-paracetamol"/>
  </identifier>
  <version value="1.0"/>
  <status value="final"/>
  <type>
    <coding>
      <system value="https://spor.ema.europa.eu/rmswi"/>
      <code value="100000155538"/>
      <display value="Package Leaflet"/>
    </coding>
  </type>
  <subject>🔗 
    <reference
               value="http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-epi-type2-example-paracetamol"/>
  </subject>
  <date value="2023-01-25"/>
  <author>🔗 
    <reference value="Organization/org-epi-type2-example-acme"/>
  </author>
  <title
         value="Package Leaflet: Information for the user - WonderDrug 500 mg tablets"/>
  <section id="root-section">
    <title value="Package Leaflet"/>
    <code>
      <coding>
        <system value="https://spor.ema.europa.eu/rmswi"/>
        <code value="100000155538"/>
        <display value="Package Leaflet"/>
      </coding>
    </code>
    <text>
      <status value="generated"/>
      <div xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">Package Leaflet</div>
    </text>
    <entry>🔗 
      <reference value="Organization/org-epi-type2-example-acme"/>
    </entry>
    <entry>🔗 
      <reference
                 value="MedicinalProductDefinition/mpd-epi-type2-example-paracetamol"/>
    </entry>
    <section id="section-1">
      <title value="1. What is in this leaflet"/>
      <code>
        <coding>
          <system value="https://spor.ema.europa.eu/rmswi"/>
          <code value="100000155538"/>
          <display value="1. What is in this leaflet"/>
        </coding>
      </code>
      <text>
        <status value="generated"/>
        <div xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en"><h2>1. What is in this leaflet</h2><p>Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.</p></div>
      </text>
    </section>
  </section>
</Composition>